The Many Problems With the FDA’s Big Menopause Announcement

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.

On Monday, the Department of Health and Human Services (HHS) made an announcement that it promised would change the lives of millions of American women for the better: hormone replacement therapy (HRT), the combination of hormone drugs that can treat the symptoms of menopause, was about to be depathologized.

The Food and Drug Administration (FDA) had decided to remove a black-box warning on the medication that cautioned patients that its use could cause cancer and stroke. HHS Secretary RFK Jr. and FDA commissioner Marty Makary said that the warning, which first appeared in 2003, had been based on an overblown interpretation of a decades-old study.

“The FDA is announcing today that it will remove the misleading black-box warnings from all HRT products,” said Kennedy. “For the first time in a generation, the FDA is standing with science and standing with women.”

The change was welcome news to many doctors who treat the often-debilitating and long-dismissed symptoms of menopause: hot flashes, brain fog, insomnia, and recurrent urinary tract infections, to name but a few.

“This decision aligns with the latest evidence-based research and helps eliminate the unnecessary fear that this warning has long perpetuated,” the Menopause Advocacy Working Group, a group of physicians that promotes increased awareness around menopause, said in a statement on social media. (Two of the group’s members were among the speakers at Monday’s event.)

However, specialists with whom Mother Jones spoke noted that Monday’s panel, which included doctors with robust social media presences, at times overstated both the negative health effects of menopause and the science on the benefits of hormone replacement therapy.

Spokespeople for HHS did not immediately respond to questions for this story.

Here are just a few of the more questionable claims made during the panel:

### Menopause causes divorce.

Dr. Kelly Casperson, a urologist and “expert and advocate for sexuality and hormones,” warned that “families fracture” if women don’t get treated for the symptoms of menopause. Dr. Makary listed “divorce” alongside well-documented symptoms like mood swings and hot flashes.

For Adrian Sandra Dobs, a professor of Medicine and Oncology at the Johns Hopkins University School of Medicine’s Division of Endocrinology, Diabetes and Metabolism, this claim was “pretty ridiculous.”

She continued, “It is true that there can be mood swings and this can affect a marriage,” but to blame a divorce on menopause is “really stretching it.”

### Menopause kills women.

“HRT has saved marriages, rescued women from depression, prevented children from going without a mother,” Dr. Makary said.

“Menopause shortens women’s lives,” added HHS Advanced Research Projects Agency for Health Director Alicia Jackson.

Dr. Esther Eisenberg, a Professor Emerita at Vanderbilt University Medical Center who is working on the American Congress of Obstetricians and Gynecologists’ (ACOG) forthcoming guide to menopause, called the notion that menopause kills women “absurd.”

Menopause, she said, “has nothing to do with a woman’s lifespan.”

Dr. Jen Gunter, a gynecologist and the author of the 2021 book *The Menopause Manifesto*, noted in a Bluesky post that, on average, women actually live longer than men.

### HRT improves the lives of all women.

“We have the opportunity to add up to a decade of healthy years to the life of every woman that you love!” proclaimed Dr. Jackson.

However, as Drs. Dobs and Eisenberg noted, millions of women have contraindications to HRT, such as those with a previous history of blood clots or stroke, certain blood conditions, and many with a history of breast cancer.

### Lifelong vaginal estrogen therapy helps breast cancer patients live longer.

“They need their oncologist to know that women with breast cancer who use it may actually live longer, and they need their primary doctors to know how to write the prescription, recommend it for life,” said panel member Dr. Rachel Rubin, a urologist and sexual medicine specialist.

Dr. Dobs wasn’t so sure. “I can’t agree with that,” she told Mother Jones. “We shouldn’t be afraid of it, but I couldn’t make a statement that vaginal estrogen makes women with breast cancer live longer.”

(Breast cancer patients and survivors are typically advised to avoid most forms of HRT, though emerging evidence suggests vaginal estrogen may be safer.)

### Doctors should test the estrogen levels of patients in perimenopause before prescribing HRT.

“We are sticking with our philosophy that the government is not your doctor,” said Dr. Makary. Nonetheless, he did recommend “having a doctor evaluate your estrogen levels to figure out when is the right time to start.”

Yet the North American Menopause Society explicitly recommends against testing for estrogen levels in perimenopausal women because they fluctuate so much throughout a woman’s cycle. Instead, doctors should prescribe estrogen based on a woman’s symptoms.

Of Makary’s advice for women to ask their doctors to test their estrogen levels, Dr. Eisenberg said, “that recommendation comes out of the sky.”

Makary cast these claims as the results not only of “a robust review of the latest scientific evidence” but also of “listening to women who have been challenging the paternalism of medicine.”

In a surprisingly feminist statement, Makary added, “A male-dominated medical profession, let’s be honest, has minimized the symptoms of menopause, and as a result, women’s health issues have not received the attention that they deserve.”

Makary’s criticism of paternalism in medicine might strike some as particularly ironic given some of the other recent actions the FDA has taken on women’s health, which have included adding warnings to medications already proven to be safe.

Back in July, for instance, the agency convened a so-called expert panel to discuss the use of antidepressants by pregnant women. The event featured a majority-male panel, several of whom called for adding a black-box warning to SSRIs for pregnant women — a warning that reproductive health experts say could increase stigma for women who could benefit from taking the pills.

The members of that panel mostly spewed misinformation while railing against the use of antidepressants during pregnancy, to such an extent that the president of ACOG promptly released a statement calling the meeting an “alarmingly unbalanced” event that “did not adequately acknowledge the harms of untreated perinatal mood disorders in pregnancy.”

In addition, Kennedy and Makary confirmed in a September letter to Republican attorneys general that they would undertake a review of the safety of mifepristone, one of the two drugs used in medication abortion, even though more than 100 scientific studies have confirmed the pills are safe and effective — including when they are prescribed virtually and mailed to patients.

Reproductive rights advocates are concerned that this “review” could lead to a decision to restrict access to the pills by recommending they not be prescribed virtually and mailed, or that they should not be used through ten weeks’ gestation, as the FDA currently allows.

(Abortion advocates say the pills can be safely used later in pregnancy, and the World Health Organization guidelines note they can be used anytime in the first trimester.)

The newfound enthusiasm for HRT has been building over the past few years, as awareness of menopause, its symptoms, and the myths around hormonal medications has increased.

All the attention on menopause, though, has elevated a new cadre of doctor-influencers, two of whom were featured speakers at Monday’s event.

– Casperson, a urologist who hosts a podcast and has written two books about menopause and sex, has 435,000 Instagram followers. At her Bellingham, Washington clinic, which doesn’t accept insurance and instead offers memberships starting at $3,000 for 4-6 months of treatment, Casperson says she aims to help women “stop should-ing all over your sex life.”

– Rubin, also a urologist who doesn’t accept insurance, has 185,000 followers on Instagram. She trained under controversial physician Irwin Goldstein, who advocated for the first-ever women’s libido drug approved by the FDA in 2015.

Dr. Dobs cautions against relying on influencers selling supplements or claiming that HRT will solve all women’s health problems.

“Unfortunately, nothing really keeps us young except things like stopping smoking, exercising, and lifestyle modification,” she said. “There’s a lot of hype to hormones — we think they’re going to cure everything, and they really don’t.”
https://www.motherjones.com/politics/2025/11/the-many-problems-with-the-fdas-big-menopause-announcement/

Knicks Most Logical Trade Fit for 4-Time Champion: NBA Insiders

If the Los Angeles Lakers decide to part ways with LeBron James midseason, multiple NBA insiders believe there’s one clear destination that makes the most sense: the New York Knicks.

During a recent episode of *The Kevin O’Connor Show*, Yahoo Sports’ Kevin O’Connor and ESPN front office insider Bobby Marks discussed the growing speculation surrounding James’ future and identified the Knicks as the most “plausible” landing spot should the Lakers move their superstar before the trade deadline.

“Yeah, I’d say the Knicks for sure,” O’Connor said. “I’d say Knicks number one and then everybody else. If he were to be traded midseason, the Knicks make sense for salary purposes, for roster fit purposes, for what they could desire — what they feel like they might need to take a leap.”

### Bobby Marks: Knicks ‘Have the Contracts’

Marks broke down several possible outcomes for the 40-year-old forward’s future, explaining how financial restrictions would shape the trade landscape.

“If [LeBron] ever said, ‘I want to be bought out,’ we basically eliminate all the apron teams,” Marks explained. “So we eliminate the Clevelands and the Dallas’s and the Golden States and New York and that whole contingent.”

However, Marks quickly clarified that in a straight trade scenario, New York rises to the top.

“If it were a straight trade, I think we can eliminate Cleveland. I think Dallas would probably be eliminated too — they’d have to gut it for LeBron,” Marks continued. “You always think New York, potentially. They have the contracts, the big [Karl-Anthony] Towns number, or OG [Anunoby]-[Mikal] Bridges combo, whatever it might be. That group, I think, would probably lean back toward New York.”

### LeBron’s Madison Square Garden Connection Adds Intrigue

O’Connor emphasized that the fit isn’t just about cap flexibility — it’s also about legacy.

“It’s Madison Square Garden,” O’Connor said. “LeBron’s always called it his favorite arena. He could be a quote-unquote savior if he helps take them to a championship for the first time in decades.”

James’ long-standing admiration for New York City and the Knicks’ iconic venue has been well-documented throughout his career. In early 2024, James admitted that he seriously considered signing with New York during his 2010 free agency.

A trade to the Knicks would represent a full-circle moment — a late-career chapter where the four-time MVP could chase one final championship while rejuvenating the NBA’s most starved franchise.

### Potentially Bigger than Luka Trade

If such a deal were to happen, O’Connor said it would be the biggest trade in NBA history, even eclipsing the blockbuster move that sent Luka Dončić to Los Angeles last year.

“Can you imagine that? LeBron James traded midseason to the New York Knicks,” O’Connor said. “Talk about breaking social media if Shams [Charania] drops that bomb, it might even exceed the Luka trade last year.”

### Lakers Face Uncertain Future as LeBron Nears 41

While insiders like O’Connor and Marks see New York as the most logical landing spot, oddsmakers aren’t convinced. According to Bovada, the Knicks currently hold the fourth-best odds (+550) to land James if he’s traded.

The Dallas Mavericks (-120) remain the betting favorite, followed by the Cleveland Cavaliers (+350), James’ former team, and the Golden State Warriors (+450). The Miami Heat and Phoenix Suns round out the top six at +900 each.

Now entering the final year of his contract, James’ future in Los Angeles remains clouded. The 40-year-old superstar is currently sidelined with sciatica and expected to miss three to four weeks, per ESPN’s Shams Charania.

“LeBron’s gonna be watching while he’s out,” ESPN’s Dave McMenamin said on *NBA Today*. “If they’re struggling, that could lead to the next step — maybe he’s gonna have to go elsewhere to find that winning combination.”

### What a Knicks Move Would Mean for LeBron’s Legacy

For LeBron, joining the Knicks would be more than a basketball decision — it would be a legacy-defining gamble. If he were to lead New York to its first NBA title since 1973, it could cement his status as the league’s ultimate franchise savior.

As trade speculation swirls and Bovada’s odds shift week to week, one thing is clear: the LeBron-to-New York storyline has moved from fantasy to feasible talking point. And if it ever happens, as O’Connor put it, it wouldn’t just dominate the headlines — it would “break social media.”
https://heavy.com/sports/nba/new-york-knicks/lebron-trade-fit-2/